Sundar Jagannath, MDDS

home / authors / sundar-jagannath-mdds

Articles

Dr. Jagannath Discusses the STORM and STOMP Trials for Patients With Multiple Myeloma

September 12th 2017

Sundar Jagannath, MDDS, professor, Medicine, Hematology, and Medical Oncology, Mount Sinai Hospital, discusses the STORM and STOMP clinical trials  in patients with multiple myeloma.

Mechanism of Action of Selinexor for the Treatment of Multiple Myeloma

Sundar Jagannath, MDDS

July 18th 2017

Sundar Jagannath, MDDS, professor, Medicine, Hematology, and Medical Oncology, Mount Sinai Hospital, discusses the mechanism of action of selinexor for the treatment of multiple myeloma.

An Overview of a Study of bb2121 in Multiple Myeloma

Sundar Jagannath, MDDS

June 30th 2017

Sundar Jagannath, MDDS, professor, Medicine, Hematology, and Medical Oncology, Mount Sinai Hospital, discusses a first in-human multicenter study of bb2121 anti-BCMA CAR T-cell therapy for relapsed/refractory multiple myeloma.